Jaguar Health, Inc. Announces 1-for-3 Reverse Stock Split
Reverse split approved by majority of common stock shareholders at December 2020 special meeting of stockholdersShares of Jaguar common stock...
Day: September 3, 2021
EastWest Bioscience Adds Self-Storage to its Penticton Facility
PENTICTON, BC / ACCESSWIRE / September 3, 2021 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that it is...
Jaguar Health Reports Voting Results from 2021 Annual Meeting of Stockholders
Proposals 1, 2, 4, 5 & 6 approvedSAN FRANCISCO, CA / ACCESSWIRE / September 3, 2021 / Jaguar Health, Inc....
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its...
Ortho Clinical Diagnostics to Participate in September Investor Conferences
RARITAN, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest...
Flexion Therapeutics to Present at the Wells Fargo 2021 Virtual Healthcare Conference
BURLINGTON, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and...
Nautilus to Participate in the Morgan Stanley Global Healthcare Conference
SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
TRUDHESA Is the First and Only Therapeutic to Use POD technology to Deliver Dihydroergotamine Mesylate (DHE) to the Vascular-Rich Upper...
Assure Holdings Announces Application for NASDAQ Listing
Assure to Effect Share Consolidation and Corporate Governance Changes to Comply with NASDAQ Capital Market Listing Requirements DENVER, Sept. 03,...
Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
Company announcement – No. 57 / 2021 Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference Copenhagen,...
Pharvaris to Participate in Upcoming September Investor Conferences
ZUG, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization...
ProQR Announces Upcoming Investor Conferences
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company...
RAPT Therapeutics to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...
BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company...
G1 Therapeutics to Participate in Two Upcoming September Conferences
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
Glaukos Announces Submission of Supplemental Pre-Market Approval Application for iStent infinite™
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...